News - Lipitor

Filter

Current filters:

Lipitor

Popular Filters

US launch of generic Lipitor confirms value of competition, says GPhA

01-12-2011

Commenting on this week’s US roll out for generic copies of Pfizer blockbuster cholesterol lowerer…

GenericsLipitorMarkets & MarketingNorth AmericaPatentsPfizerRanbaxy LaboratoriesWatson Pharmaceuticals

Mixed results for AstraZeneca in study comparing Crestor with Lipitor

16-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) presented mixed results from a study comparing its cholesterol…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

AstraZeneca launches new Crestor savings card in USA, as generic Lipitor about to debut

07-11-2011

The US subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched a new savings…

AstraZenecaCardio-vascularCrestorGenericsLipitorNorth AmericaPfizerPharmaceuticalPricing

AstraZeneca’s Crestor fails to show significant improvement over Lipitor

05-09-2011

There was a big disappointment for Anglo-Swedish drug major AstraZeneca (LSE: AZN) on Friday, when it…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

Pfizer in generic Lipitor deals with Sanofi and Dr Reddy’s

01-09-2011

Global drugs behemoth Pfizer (NYSE: PFE) has reached agreement with French drug major Sanofi (Euronext:…

atorvastatinCardio-vascularDr Reddy's LaboratoriesGenericsLegalLicensingLipitorPfizerSanofiZentiva

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched

11-07-2011

US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…

BayerCardio-vascularEuropeGenericsLipitorPatentsPfizerPharmaceuticalReproductiveYasmin

Teva sold generic Lipitor in UK, despite ongoing patent proection, FT reports

04-07-2011

Despite the fact that US drugs behemoth Pfizer (NYSE: PFE) has patent protection for its blockbuster…

Cardio-vascularEuropeGenericsLipitorMarkets & MarketingPatentsPfizerTeva Pharmaceutical Industries

Humira to assume Lipitor's crown as Pfizer feels the heat from Sanofi and Novartis

29-06-2011

Rheumatoid arthritis treatment Humira (adalimumab) from Abbott Laboratories (NYSE: ABT) will assume Lipitor's…

Abbott LaboratoriesFinancialHumiraLipitorMarkets & MarketingNovartisPatentsPfizerPharmaceuticalSanofi

Back to top